Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The New York Times and Foreign Policy offer analyses of Republican Presidential nominee Mitt Romney’s foreign policy and international development stance.
Scientists have found alarming levels of drug-resistant tuberculosis in Africa, Asia, Europe, and Latin America, reinforcing the urgent need to develop new treatment options.
Gilead Sciences has received US Food and Drug Administration approval for a new HIV and AIDS treatment that combines four of the company’s drugs into one.
The PATH Malaria Vaccine Initiative has teamed up with the International AIDS Vaccine Initiative and Imperial College London to establish a reference laboratory for measuring immune responses, as more vaccine candidates move into clinical trials.
A World Intellectual Property Organization project that aims to promote research for neglected diseases through an intellectual property database has announced the conclusion of its first research agreements.
Researchers at the University of Cape Town recently reported promising developments in their effort to develop a single-dose cure for malaria.